Computational ADME, Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Bioorg Med Chem Lett. 2012 Nov 1;22(21):6540-8. doi: 10.1016/j.bmcl.2012.08.059. Epub 2012 Aug 23.
The requirement to cross a biological membrane can be a complex process especially if multidrug transporters such as P-gp must be considered. Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role. All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength. Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramolecular H-bonds to increase membrane permeability and/or decrease P-gp efflux.
跨膜的要求可能是一个复杂的过程,特别是如果要考虑多药转运蛋白(如 P-糖蛋白)的话。药物进入脂质膜的分配和 P-糖蛋白的外排是紧密偶联的过程,其中氢键相互作用起着关键作用。所有的氢键供体和受体在形成氢键的强度方面并不相同,因此考虑它们的相对强度是很重要的。我们通过文献中的各种例子说明了考虑单个氢键的相对强度以及引入分子内氢键来增加膜通透性和/或降低 P-糖蛋白外排的好处。